Biolase EBITDA 2010-2024 | BIOL
Biolase ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Biolase Annual EBITDA
(Millions of US $) |
| 2023 |
$-15 |
| 2022 |
$-24 |
| 2021 |
$-16 |
| 2020 |
$-18 |
| 2019 |
$-14 |
| 2018 |
$-20 |
| 2017 |
$-17 |
| 2016 |
$-14 |
| 2015 |
$-19 |
| 2014 |
$-17 |
| 2013 |
$-10 |
| 2012 |
$-2 |
| 2011 |
$-3 |
| 2010 |
$-10 |
| 2009 |
$-2 |
Biolase Quarterly EBITDA
(Millions of US $) |
| 2024-06-30 |
$-2 |
| 2024-03-31 |
$-4 |
| 2023-12-31 |
$-4 |
| 2023-09-30 |
$-3 |
| 2023-06-30 |
$-2 |
| 2023-03-31 |
$-5 |
| 2022-12-31 |
$-7 |
| 2022-09-30 |
$-7 |
| 2022-06-30 |
$-5 |
| 2022-03-31 |
$-4 |
| 2021-12-31 |
$-4 |
| 2021-09-30 |
$-2 |
| 2021-06-30 |
$-3 |
| 2021-03-31 |
$-6 |
| 2020-12-31 |
$-5 |
| 2020-09-30 |
$-3 |
| 2020-06-30 |
$-4 |
| 2020-03-31 |
$-5 |
| 2019-12-31 |
$-3 |
| 2019-09-30 |
$-5 |
| 2019-06-30 |
$-3 |
| 2019-03-31 |
$-4 |
| 2018-12-31 |
$-6 |
| 2018-09-30 |
$-4 |
| 2018-06-30 |
$-4 |
| 2018-03-31 |
$-5 |
| 2017-12-31 |
$-4 |
| 2017-09-30 |
$-4 |
| 2017-06-30 |
$-4 |
| 2017-03-31 |
$-4 |
| 2016-12-31 |
$-4 |
| 2016-09-30 |
$-3 |
| 2016-06-30 |
$-3 |
| 2016-03-31 |
$-4 |
| 2015-12-31 |
$-2 |
| 2015-09-30 |
$-5 |
| 2015-06-30 |
$-7 |
| 2015-03-31 |
$-5 |
| 2014-12-31 |
$-4 |
| 2014-09-30 |
$-3 |
| 2014-06-30 |
$-6 |
| 2014-03-31 |
$-4 |
| 2013-12-31 |
$-2 |
| 2013-09-30 |
$-4 |
| 2013-06-30 |
$-2 |
| 2013-03-31 |
$-3 |
| 2012-12-31 |
$1 |
| 2012-09-30 |
$-0 |
| 2012-06-30 |
$-2 |
| 2012-03-31 |
$-1 |
| 2011-12-31 |
$-2 |
| 2011-09-30 |
$-1 |
| 2011-06-30 |
$-1 |
| 2011-03-31 |
$-0 |
| 2010-12-31 |
$1 |
| 2010-09-30 |
$-2 |
| 2010-06-30 |
$-4 |
| 2010-03-31 |
$-5 |
| 2009-12-31 |
$-1 |
| 2009-09-30 |
$1 |
| 2009-06-30 |
$3 |
| 2009-03-31 |
$-5 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.002B |
$0.049B |
|
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
|
